Drug Development
Phase III trial of Neurodex initiated for diabetic neuropathic pain
Published in Obesity and Diabetes Week, July 18th, 2005
The randomized, placebo-controlled study will assess efficacy, overall safety and tolerability of Avanir's investigational drug targeting central nervous system (CNS) receptors to treat diabetic neuropathic pain.
The 3-month study will assess the efficacy of Neurodex in relieving pain in adult patients with distal symmetrical diabetic neuropathy with daily pain in the lower extremities. The clinical trial will be conducted at 40 sites in the United States and will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathology
Aerobic exercise helps find genetic regions linked to prediabetes - Diabetes Therapy
Barriers to diabetes education in urban patients presented - Diabetic Complications
Pioglitazone HCL significantly improves components of diabetic dyslipidemia - Diet and Nutrition
Statistics provide information on dietary factors in type 2 diabetes - Hypoglycemia
Low plasma glucose levels associated with lower gestational diabetes incidence - Amyotrophic Lateral Sclerosis
Phase II trial for ALS expected to begin after second quarter - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
